Literature DB >> 16143584

Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases.

N Teig1, A Anders, C Schmidt, C Rieger, S Gatermann.   

Abstract

BACKGROUND: Persistent infection with Mycoplasma pneumoniae and Chlamydophila pneumoniae has been implicated in the progression or induction of asthma and chronic obstructive pulmonary disease. Evidence for this hypothesis has been obtained in adults either by serological methods or by direct pathogen detection using invasive procedures.
METHODS: We investigated nasal brush specimens and induced sputum from 38 children with stable chronic lung disease (asthma, n = 26; chronic bronchitis n = 12) and from 42 healthy controls for the presence of M pneumoniae or C. pneumoniae DNA by polymerase chain reaction (PCR) using nested primers.
RESULTS: None of the controls but 23.6% and 10.5% of the children with lung disease had positive PCR for C pneumoniae (p = 0.001) and M pneumoniae (p = 0.044) respectively. Significantly more children with non-atopic asthma than with atopic asthma were positive for C pneumoniae or M pneumoniae (4/8 v 1/18; p = 0.018). There were no unwanted side effects from sputum induction. No correlation was found between detection of Chlamydophila and severity of lung disease. Colonisation with both organisms had occurred before adulthood in a significant proportion of children with stable chronic lung diseases.
CONCLUSION: Combining nasal brush specimens with induced sputum may be a useful non-invasive method for studying the role of C pneumoniae and M pneumoniae infection in children with different chronic lung diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143584      PMCID: PMC1747249          DOI: 10.1136/thx.2005.041004

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  47 in total

1.  Chlamydia pneumoniae serological status is not associated with asthma in children or young adults.

Authors:  G D Mills; J A Lindeman; J P Fawcett; G P Herbison; M R Sears
Journal:  Int J Epidemiol       Date:  2000-04       Impact factor: 7.196

Review 2.  Is Chlamydia pneumoniae important in asthma? The first controlled trial of therapy leaves the question unanswered.

Authors:  S L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

3.  Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease.

Authors:  L Wu; S J Skinner; N Lambie; J C Vuletic; F Blasi; P N Black
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

4.  Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?

Authors:  I W Fong; B Chiu; E Viira; D Jang; M W Fong; R Peeling; J B Mahony
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Asthma, atopy and Chlamydia pneumoniae antibodies in adults.

Authors:  L Von Hertzen; M Töyrylä; A Gimishanov; A Bloigu; M Leinonen; P Saikku; T Haahtela
Journal:  Clin Exp Allergy       Date:  1999-04       Impact factor: 5.018

6.  Bronchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children.

Authors:  S M Schmidt; C E Müller; R Bruns; S K Wiersbitzky
Journal:  Pediatr Allergy Immunol       Date:  2001-10       Impact factor: 6.377

7.  Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study.

Authors:  T Heiskanen-Kosma; M Korppi; A Laurila; C Jokinen; M Kleemola; P Saikku
Journal:  Scand J Infect Dis       Date:  1999

8.  Increased frequency of detection of Chlamydophila pneumoniae in asthma.

Authors:  G L Biscione; J Corne; A J Chauhan; S L Johnston
Journal:  Eur Respir J       Date:  2004-11       Impact factor: 16.671

Review 9.  Animal models for Chlamydia pneumoniae infection.

Authors:  P Saikku; K Laitinen; M Leinonen
Journal:  Atherosclerosis       Date:  1998-10       Impact factor: 5.162

10.  Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children.

Authors:  F Freymuth; A Vabret; J Brouard; F Toutain; R Verdon; J Petitjean; S Gouarin; J F Duhamel; B Guillois
Journal:  J Clin Virol       Date:  1999-08       Impact factor: 3.168

View more
  10 in total

Review 1.  New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.

Authors:  Ken B Waites; Mitchell F Balish; T Prescott Atkinson
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

2.  Chlamydophila pneumoniae and Mycoplasma pneumoniae were not identified in sinus mucosa of patients with chronic rhinosinusitis.

Authors:  Nenad Pandak; Ivana Pajić-Penavić; Snježana Židovec-Lepej; Ana Planinić; Biserka Trošelj-Vukić; Ljiljana Perić
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-06       Impact factor: 2.503

3.  Isolation of Chlamydia pneumoniae from serum samples of the patients with acute coronary syndrome.

Authors:  Ivan M Petyaev; Nayilia A Zigangirova; Alexey M Petyaev; Ulia P Pashko; Lubov V Didenko; Elena U Morgunova; Yuriy K Bashmakov
Journal:  Int J Med Sci       Date:  2010-06-10       Impact factor: 3.738

4.  Epidemiology and associations with climatic conditions of Mycoplasma pneumoniae and Chlamydophila pneumoniae infections among Chinese children hospitalized with acute respiratory infections.

Authors:  Zhengrong Chen; Wei Ji; Yuqing Wang; Yongdong Yan; Hong Zhu; Xuejun Shao; Jun Xu
Journal:  Ital J Pediatr       Date:  2013-05-25       Impact factor: 2.638

5.  Mycoplasma pneumoniae infection and environmental tobacco smoke inhibit lung glutathione adaptive responses and increase oxidative stress.

Authors:  Chirag Kariya; Hong Wei Chu; Jie Huang; Heather Leitner; Richard J Martin; Brian J Day
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

6.  Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction.

Authors:  Khalil Ansarin; Siavoush Abedi; Reza Ghotaslou; Mohammad Hossein Soroush; Kamyar Ghabili; Kenneth R Chapman
Journal:  Int J Gen Med       Date:  2010-12-20

Review 7.  Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria.

Authors:  Judith Miklossy
Journal:  J Neuroinflammation       Date:  2011-08-04       Impact factor: 8.322

8.  Epidemiology and molecular identification of mycoplasma pneumoniae associated with respiratory infections in Zhejiang province, China, 2008-2017.

Authors:  Qian Jiang; Fangfang Yang; Yumeng Peng; XiaoYan Dong; Yumei Ge
Journal:  J Clin Lab Anal       Date:  2020-07-14       Impact factor: 2.352

Review 9.  Insights into the pathogenesis of Mycoplasma pneumoniae (Review).

Authors:  Jun He; Mihua Liu; Zhufeng Ye; Tianping Tan; Xinghui Liu; Xiaoxing You; Yanhua Zeng; Yimou Wu
Journal:  Mol Med Rep       Date:  2016-09-23       Impact factor: 2.952

10.  Association of Mycoplasma pneumoniae and asthma among Indian children.

Authors:  Avanish K Varshney; Rama Chaudhry; Sunil Saharan; Sushil Kumar Kabra; Benu Dhawan; Lalit Dar; Pawan Malhotra
Journal:  FEMS Immunol Med Microbiol       Date:  2009-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.